ArticleThe Journal of clinical investigation2025

ACAT1 regulates tertiary lymphoid structures: A target for enhancing immunotherapy in non-small cell lung cancer.

Sophie O'Keefe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.